Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael G Kirby

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
BJU International|December 21, 2006
Diabetes and the urologist: a growing problemMiles A Goldstraw, Michael G Kirby, Jeetesh Bhardwa, et al.
Sexual Medicine Reviews|July 2, 2018
Cardiovascular Safety of Phosphodiesterase Type 5 Inhibitors After Nearly 2 Decades on the MarketRobert A Kloner, Irwin Goldstein, Michael G Kirby, et al.
International Journal of Clinical Practice|December 1, 2020
The management of sexual dysfunction resulting from radiotherapy and androgen deprivation therapy to treat prostate cancer: A comparison of uro-oncology practice according to disease stageWilliam Kinnaird, Michael G Kirby, Anita Mitra, et al.
Neurourology and Urodynamics|March 16, 2012
Overactive bladder symptoms and voiding dysfunction in neurologically normal womenMontserrat Espuña-Pons, Linda Cardozo, Christopher Chapple, et al.
Sexual Medicine Reviews|February 23, 2026
Sexual function in chronic illness and cancer perspectives of the patient, partner, and healthcare provider; innovations; and updates: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024)Kevan Richard Wylie, Michael G Kirby, Filippo Maria Nimbi, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|May 10, 2018
A New Perspective on the Nitrate-Phosphodiesterase Type 5 Inhibitor InteractionRobert A Kloner, Paul Goggin, Irwin Goldstein, et al.
International Journal of Clinical Practice|October 2, 2019
Prescription switching: Rationales and risksMichael G Kirby, Paula Allchorne, Tim Appanna, et al.
Research in Social & Administrative Pharmacy : RSAP|July 31, 2018
The pharmacist's role in improving the treatment of erectile dysfunction and its underlying causesDavid G Taylor, Francois Giuliano, Geoff Hackett, et al.
Neurourology and Urodynamics|July 1, 2010
Overactive bladder: Is there a link to the metabolic syndrome in men?Michael G Kirby, Adrian Wagg, Linda Cardozo, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
BJU International|December 21, 2006
Diabetes and the urologist: a growing problemMiles A Goldstraw, Michael G Kirby, Jeetesh Bhardwa, et al.
Sexual Medicine Reviews|July 2, 2018
Cardiovascular Safety of Phosphodiesterase Type 5 Inhibitors After Nearly 2 Decades on the MarketRobert A Kloner, Irwin Goldstein, Michael G Kirby, et al.
International Journal of Clinical Practice|December 1, 2020
The management of sexual dysfunction resulting from radiotherapy and androgen deprivation therapy to treat prostate cancer: A comparison of uro-oncology practice according to disease stageWilliam Kinnaird, Michael G Kirby, Anita Mitra, et al.
Neurourology and Urodynamics|March 16, 2012
Overactive bladder symptoms and voiding dysfunction in neurologically normal womenMontserrat Espuña-Pons, Linda Cardozo, Christopher Chapple, et al.
Sexual Medicine Reviews|February 23, 2026
Sexual function in chronic illness and cancer perspectives of the patient, partner, and healthcare provider; innovations; and updates: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024)Kevan Richard Wylie, Michael G Kirby, Filippo Maria Nimbi, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|May 10, 2018
A New Perspective on the Nitrate-Phosphodiesterase Type 5 Inhibitor InteractionRobert A Kloner, Paul Goggin, Irwin Goldstein, et al.
International Journal of Clinical Practice|October 2, 2019
Prescription switching: Rationales and risksMichael G Kirby, Paula Allchorne, Tim Appanna, et al.
Research in Social & Administrative Pharmacy : RSAP|July 31, 2018
The pharmacist's role in improving the treatment of erectile dysfunction and its underlying causesDavid G Taylor, Francois Giuliano, Geoff Hackett, et al.
Neurourology and Urodynamics|July 1, 2010
Overactive bladder: Is there a link to the metabolic syndrome in men?Michael G Kirby, Adrian Wagg, Linda Cardozo, et al.
Pageof 1